Semaglutide targets only the GLP-1 receptor, while the dual-action design of Tirzepatide also activates GIP receptorsleading to more robust weight loss results in most head-to-head trials
10.1007/s00775-020-01761-8 18 BorahS.MishraR.DeyS.SuchantiS.BhowmickN
As a boosted side effect, it also helps diabetics lose some weight, especially when combined with a healthy diet and getting enough exercise
The HPLC-DAD method is limited by its sensitivity, which results in higher LOQ (3.5 pmol mg 1 protein) compared to HPLC-TLS (LOQ = 0.12 pmol mg 1 protein) and consequently in higher measurement error and therefore in lower accuracy of the results
Front Pharmacol 2020;11:1270.ArticlePubMedPMC 84
It has been used to treat neurological diseases such as Huntingtons chorea, Tourettes disease, cerebellar ataxia and certain types of seizures